Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2014-11-30
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tart Cherry Juice and Markers of Inflammation, CVD, and Diabetes
NCT03636529
Effect of Cherry Juice on Fat Oxidation and Cardio-metabolic Markers
NCT02999256
The Effect of Tart Cherry (Prunus Cerasus) Concentrate on Physiological and Cognitive Function
NCT04021342
Tart Cherry Juice and Chronic Disease Risk
NCT03638362
Acute Effects of Tart Cherry on Uric Acid and Biomarkers of CVD Risk in Healthy Individuals
NCT04960527
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tart cherry juice
Participants consumed 16 fl. oz of tart cherry juice daily for 12 weeks.
Tart cherry juice
16 fl. oz of tart cherry juice
Placebo juice
Participants consumed 16 fl. oz of placebo daily for 12 weeks.
Placebo
16 fl. oz of placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tart cherry juice
16 fl. oz of tart cherry juice
Placebo
16 fl. oz of placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Heavy smoker
* Taking medications that affect cognitive function
* History of neurological disorders
* History of traumatic brain injury
* History of stroke
* Clinical diagnosis of diabetes
* Clinical diagnosis of Alzheimer's Disease/Dementia
* GI disease
* Kidney disease
* Liver disease
* Cancer
65 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Delaware
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheau Ching Chai
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sheau Ching Chai, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
University of Delaware
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Delaware
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15A00149
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.